The American College of Radiology recently updated its Appropriateness Criteria (guidelines) for early stage prostate cancer indicating that stereotactic body radiation therapy (SBRT) may help patients diagnosed with prostate cancer.
According to the report, “There are growing data to suggest that hypofractionation on a dose-per-fraction less than 3.0 Gy per fraction is reasonably safe and efficacious, and although the early results from hypofractionation/SBRT studies at dose-per-fraction greater than 4.0 Gy appear promising, these approaches should continue to be used with caution until more mature, ongoing phase II and III randomized controlled studies have been completed.”
SBRT for prostate cancer involves five or fewer treatment sessions, minimizing disruption to men’s normal routines and lifestyles. Click here for a complete copy of the guidelines.
The American College of Radiology is made up of 36,000 members including radiologists, radiation oncologists, medical physicists, interventional radiologists, nuclear medicine physicians and allied health professionals.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.